ExodusPoint Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,327
| Closed | -$544K | – | 2123 |
|
|
2022
Q4 | $544K | Sell |
14,327
-19,267
| -57% | -$732K | 0.01% | 1109 |
|
|
2022
Q3 | $844K | Sell |
33,594
-88,156
| -72% | -$2.21M | 0.01% | 1145 |
|
|
2022
Q2 | $3.7M | Buy |
121,750
+106,927
| +721% | +$3.25M | 0.05% | 485 |
|
|
2022
Q1 | $486K | Sell |
14,823
-50,735
| -77% | -$1.66M | 0.01% | 1496 |
|
|
2021
Q4 | $1.73M | Buy |
+65,558
| New | +$1.73M | 0.02% | 782 |
|
|
2021
Q2 | – | Sell |
-22,123
| Closed | -$2.21M | – | 2863 |
|
|
2021
Q1 | $2.21M | Buy |
22,123
+16,479
| +292% | +$1.64M | 0.03% | 506 |
|
|
2020
Q4 | $698K | Buy |
+5,644
| New | +$698K | 0.01% | 988 |
|
|
2020
Q3 | – | Sell |
-15,298
| Closed | -$2.39M | – | 2286 |
|
|
2020
Q2 | $2.39M | Buy |
15,298
+10,919
| +249% | +$1.7M | 0.06% | 344 |
|
|
2020
Q1 | $632K | Sell |
4,379
-3,268
| -43% | -$472K | 0.03% | 376 |
|
|
2019
Q4 | $1.56M | Buy |
7,647
+4,647
| +155% | +$950K | 0.03% | 357 |
|
|
2019
Q3 | $241K | Buy |
+3,000
| New | +$241K | 0.01% | 991 |
|